Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-06-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2020-01-10 Braunstein Scott Director Grant or award +26,500 26,500
2020-01-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +2,861 2,861
2020-01-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +16,214 16,214
2020-01-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +15,641 15,641
2020-01-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +9,537 9,537
2020-01-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +2,861 2,861
2020-01-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +9,537 9,537
2020-01-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +6,676 6,676
2020-01-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +15,737 15,737

Page 1 of 1 · 10 trades